-
Study aim
-
Determining the Effect of a Mobile Phone–Based Medication Reminder Application and Educational Text Messaging on Medication Adherence and Quality of Life in Patients with Acute Coronary Syndrome
-
Design
-
✅ This randomized, single-blind, controlled clinical trial with parallel groups included 66 patients(33 in each group) with multiple sclerosis, randomly selected using Random Number Generator software and assigned to intervention and control groups via Random Allocation Software.
-
Settings and conduct
-
After Ethics Committee approval and IRCT registration, patients will be randomly assigned to intervention and control groups, and informed consent will be obtained. Questionnaires will be completed before and after the intervention, which is based on the nursing process and includes education on medication, nutrition, physical activity, myocardial infarction, and stress management.
-
Participants/Inclusion and exclusion criteria
-
Definite diagnosis of acute coronary syndrome
Absence of major psychological disorders such as major depression, psychosis, etc.
Ability to use a mobile phone and possession of a personal smartphone
Ability to perform self-care, especially in taking prescribed medications
Age between 35 and 65 years
No hearing, visual, or other physical or sensory impairments
No addiction to narcotics, alcohol, or psychotropic substances
-
Intervention groups
-
For patients in the intervention group, in addition to the routine education, the “DaruYad” application will be installed on their mobile phones. The researcher will install the application for each patient and enter the required information, including prescribed medications, into the program. Moreover, patients will receive short reminder text messages for one month after discharge.
The control group will receive only the routine ward education provided before discharge
-
Main outcome variables
-
medication adherence and quality of life